G1 Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
G1 Therapeutics, Inc.‘s stocks are currently a part of 110 hedge funds’ portfolios, which represents 56.68% of the total amount of its stocks outstanding. This makes up a total of 24.11M shares of G1 Therapeutics, Inc.. Compared to the previous quarter, the number fell by -8.85% or -2.34M shares fewer. As for the holding position changes, 24.55% (27) of current hedge fund investors increased the number of shares held, 40% (44) of current holders sold a part of the shares held, and 11.82% (13) closed the holdings completely. 16 hedge funds are new holders of G1 Therapeutics, Inc. stock in Q1 2022, it is 14.55% of total holders.
Hedge funds holding G1 Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 27 |
|---|---|
| Q3 2017 | 42 |
| Q4 2017 | 57 |
| Q1 2018 | 94 |
| Q2 2018 | 95 |
| Q3 2018 | 116 |
| Q4 2018 | 93 |
| Q1 2019 | 92 |
| Q2 2019 | 94 |
| Q3 2019 | 100 |
| Q4 2019 | 98 |
| Q1 2020 | 99 |
| Q2 2020 | 100 |
| Q3 2020 | 118 |
| Q4 2020 | 124 |
| Q1 2021 | 122 |
| Q2 2021 | 113 |
| Q3 2021 | 113 |
| Q4 2021 | 107 |
| Q1 2022 | 110 |
Hedge funds changes in G1 Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 27 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2017 | 18 | 14 | 4 | 3 | 3 |
| Q4 2017 | 18 | 24 | 8 | 3 | 4 |
| Q1 2018 | 42 | 37 | 11 | 4 | 0 |
| Q2 2018 | 21 | 44 | 18 | 20 | -8 |
| Q3 2018 | 33 | 48 | 23 | 12 | 0 |
| Q4 2018 | 15 | 40 | 30 | 38 | -30 |
| Q1 2019 | 14 | 41 | 16 | 15 | 6 |
| Q2 2019 | 19 | 41 | 21 | 13 | 0 |
| Q3 2019 | 22 | 44 | 19 | 15 | 0 |
| Q4 2019 | 18 | 32 | 34 | 19 | -5 |
| Q1 2020 | 21 | 32 | 29 | 19 | -2 |
| Q2 2020 | 16 | 38 | 26 | 15 | 5 |
| Q3 2020 | 26 | 39 | 28 | 7 | 18 |
| Q4 2020 | 16 | 47 | 43 | 10 | 8 |
| Q1 2021 | 23 | 43 | 36 | 24 | -4 |
| Q2 2021 | 11 | 44 | 31 | 20 | 7 |
| Q3 2021 | 14 | 41 | 28 | 12 | 18 |
| Q4 2021 | 12 | 41 | 35 | 17 | 2 |
| Q1 2022 | 16 | 27 | 44 | 13 | 10 |
Hedge funds changes in G1 Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 5,000 | 675,000 |
| Q4 2018 | 0 | 1,000 |
| Q1 2019 | 183,000 | 178,000 |
| Q2 2019 | 401,000 | 245,000 |
| Q3 2019 | 640,000 | 5,014,000 |
| Q4 2019 | 248,000 | 4,295,000 |
| Q1 2020 | 31,000 | 0 |
| Q2 2020 | 231,000 | 269,000 |
| Q3 2020 | 2,000 | 1,764,000 |
| Q4 2020 | 2,540,000 | 7,115,000 |
| Q1 2021 | 10,858,000 | 13,081,000 |
| Q2 2021 | 7,082,000 | 6,333,000 |
| Q3 2021 | 2,801,000 | 2,467,000 |
| Q4 2021 | 1,067,000 | 1,127,000 |
| Q1 2022 | 1,239,000 | 636,000 |